Nantong Jinghua Pharmaceutical Co Ltd Net Asset Momentum
Nantong Jinghua Pharmaceutical Co Ltd net asset momentum. Nantong Jinghua Pharmaceutical Co Ltd (002349) recorded a net asset momentum of 6.5% as of December 2025, with net assets of CN¥3.15 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore Nantong Jinghua Pharmaceutical Co Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Nantong Jinghua Pharmaceutical Co Ltd (2006–2025)
Net asset momentum of Nantong Jinghua Pharmaceutical Co Ltd from 2006 to 2025. This chart tracks Nantong Jinghua Pharmaceutical Co Ltd's year-over-year net asset growth across 20 annual reporting periods from 2006 to 2025. The most recent momentum reading is +6.5%, with net assets of CN¥3.15 Billion CNY as of December 2025. See 002349 book value for net asset value and shareholders' equity analysis.
Nantong Jinghua Pharmaceutical Co Ltd Net Asset Momentum by Year (2006–2025)
Nantong Jinghua Pharmaceutical Co Ltd net asset momentum by year from 2006 to 2025. The table below shows the complete annual net asset history for Nantong Jinghua Pharmaceutical Co Ltd from 2006 to 2025, covering 20 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see Nantong Jinghua Pharmaceutical Co Ltd market capitalisation.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥3.15 Billion | CN¥3.57 Billion | CN¥421.13 Million | ▲ +6.5% |
| 2024 | CN¥2.96 Billion | CN¥3.30 Billion | CN¥344.66 Million | ▲ +5.5% |
| 2023 | CN¥2.80 Billion | CN¥3.19 Billion | CN¥380.75 Million | ▲ +6.9% |
| 2022 | CN¥2.62 Billion | CN¥3.04 Billion | CN¥417.93 Million | ▲ +2.1% |
| 2021 | CN¥2.57 Billion | CN¥3.20 Billion | CN¥628.54 Million | ▲ +3.3% |
| 2020 | CN¥2.49 Billion | CN¥3.16 Billion | CN¥669.29 Million | ▲ +15.8% |
| 2019 | CN¥2.15 Billion | CN¥2.94 Billion | CN¥793.62 Million | ▼ -20.3% |
| 2018 | CN¥2.69 Billion | CN¥3.40 Billion | CN¥705.27 Million | ▲ +1.8% |
| 2017 | CN¥2.65 Billion | CN¥3.24 Billion | CN¥594.47 Million | ▲ +15.0% |
| 2016 | CN¥2.30 Billion | CN¥2.53 Billion | CN¥227.87 Million | ▲ +3.1% |
| 2015 | CN¥2.23 Billion | CN¥2.51 Billion | CN¥272.27 Million | ▲ +45.6% |
| 2014 | CN¥1.53 Billion | CN¥1.89 Billion | CN¥351.96 Million | ▲ +106.9% |
| 2013 | CN¥741.83 Million | CN¥1.07 Billion | CN¥328.99 Million | ▲ +3.8% |
| 2012 | CN¥714.87 Million | CN¥957.71 Million | CN¥242.84 Million | ▲ +12.3% |
| 2011 | CN¥636.30 Million | CN¥780.53 Million | CN¥144.23 Million | ▲ +16.9% |
| 2010 | CN¥544.45 Million | CN¥611.41 Million | CN¥66.96 Million | ▲ +297.1% |
| 2009 | CN¥137.11 Million | CN¥220.37 Million | CN¥83.26 Million | ▲ +15.6% |
| 2008 | CN¥118.66 Million | CN¥195.95 Million | CN¥77.29 Million | ▲ +29.2% |
| 2007 | CN¥91.86 Million | CN¥200.11 Million | CN¥108.25 Million | ▲ +31.2% |
| 2006 | CN¥70.00 Million | CN¥198.19 Million | CN¥128.18 Million | — |